Search results for "steroids"

showing 10 items of 203 documents

Decreasing prevalence of specific anosmia to non-steroid odorants from childhood to adolescence

2020

International audience; Specific anosmia is defined as the inability to detect a particular odorant, despite a normal olfactory function. Previous studies reported sex-related difference in detection threshold to steroid odorants, like androstenone or androstadienone during adolescence, and boys showed an increased detection threshold with age. However, such investigations have not been performed for non-steroid odorants. Hence, the current study investigated sex- and age-related effects on the prevalence of specific anosmia in children/adolescents aged 5-14 years (n = 800) to non-steroid odorants. The detection thresholds of three non-steroid odorants (bacdanol, methylsalicylate, and 3-hyd…

MaleOlfactory systemmedicine.medical_specialtyAdolescentAnosmiamedicine.medical_treatmentExperimental and Cognitive PsychologyOlfactionBiologySteroid03 medical and health sciencesBehavioral Neurosciencechemistry.chemical_compound0302 clinical medicinechildrenInternal medicinePrevalencemedicineHumanssex0501 psychology and cognitive sciences050102 behavioral science & comparative psychologyChildnon-steroidOlfactory receptorDetection threshold05 social sciencesAndrostadienoneAndrostenonespecific anosmiaSpecific anosmiaSmellmedicine.anatomical_structureEndocrinologyagechemistryChild PreschoolSensory ThresholdsOdorants[SCCO.PSYC]Cognitive science/PsychologySteroids[SDV.AEN]Life Sciences [q-bio]/Food and Nutritionpsychological phenomena and processes030217 neurology & neurosurgeryolfactionPhysiology & Behavior
researchProduct

Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life

2020

Background: Mepolizumab (MEP) has been recently introduced to treat severe eosinophilic asthma. Trials have demonstrated a significant effectiveness in this asthma phenotype. We evaluated MEP efficacy on lung function, symptoms, asthma exacerbations, biologic markers, steroid dependence and controller treatment level in real-life. Methods: We retrospectively analyzed 134 severe asthmatics (61 males; mean age 58.3 ± 11; mean FEV1%:72 ± 21), treated with MEP for at least 6 months (mean duration:10.9 ± 3.7 months). Results: FEV1% improved significantly after MEP. Mean FEF25-75 also increased from 37.4 ± 25.4% to 47.2 ± 27.2% (p < 0.0001). Mean baseline blood eosinophil level was 712 ± 731/μ…

MaleOmalizumabFEF(25-75)step-down0302 clinical medicineMaintenance therapyAdrenal Cortex HormonesSettore MED/10Pharmacology (medical)Anti-Asthmatic Agents030212 general & internal medicinesmall airwaysAsthma exacerbationsmepolizumabMiddle AgedAnesthesiaFEF25-75CorticosteroidDrug Therapy CombinationFemalemedicine.drugPulmonary and Respiratory Medicinesevere asthmamedicine.drug_classMepolizumab Severe asthma Real-life Small airways FEF25-75 Oral corticosteroids Step-down EffectiveneseffectivenessSettore MED/10 - Malattie Dell'Apparato Respiratoriooral corticosteroidsAntibodies Monoclonal HumanizedNO03 medical and health sciencesEffectiveness FEF 25-75 Mepolizumab Oral corticosteroids Real-life Severe asthma Small airways Step-downmedicineHumansIn real lifeFEFreal-lifeAgedRetrospective StudiesBiologic markerbusiness.industryEffectivenesBiochemistry (medical)Effectiveness; FEF; 25-75; Mepolizumab; Oral corticosteroids; Real-life; Severe asthma; Small airways; Step-downAirway obstructionmedicine.diseaseAsthmaBlood Cell Countrespiratory tract diseasesAirway ObstructionEosinophils030228 respiratory systemeffectiveness; FEF(25-75); mepolizumab; oral corticosteroids; real-life; severe asthma; small airways; step-down25-75businessMepolizumab
researchProduct

Genetically engineered V79 chinese hamster cell expression of purified cytochromeP-450iib1 monooxygenase activity

1989

Chinese hamster V79 fibroblasts, frequently used as target cells in short-term tests for mutagenicity, do not possess measurable monooxygenase activity; in particular, enzymatic oxidation of testosterone (T) cannot be demonstrated. If these V79 cells, however, had been transfected with the cDNA-encoding rat liver cytochrome P-450IIB1 under control of the SV40 early promoter, they stably expressed monooxygenase activity. These so-called SD1 cells then oxidatively metabolized T at a rate of 27 pmol/mg protein/min, converting it to 16 alpha- and 16 beta-hydroxy-T as well as 4-androsten-3,17-dione as sole metabolites in a ratio of 1.1:1.0:1.6. The regio- and stereoselective conversion of T by S…

MaleOxygenaseCytochromeCellTransfectionToxicologyIsozymeChinese hamsterCricetulusCytochrome P-450 Enzyme SystemCricetinaemedicineAnimalsTestosteroneCells CulturedChromatography High Pressure Liquidchemistry.chemical_classificationbiologyRats Inbred StrainsTransfectionKetosteroidsbiology.organism_classificationMolecular biologyRatsIsoenzymesmedicine.anatomical_structureEnzymeBiochemistrychemistryPhenobarbitalMicrosomes LiverOxygenasesbiology.proteinCricetulusGenetic EngineeringOxidation-ReductionJournal of Biochemical Toxicology
researchProduct

An uncommon presentation of eosinophilic granulomatosis with polyangiitis: a case report

2013

Introduction Eosinophilic granulomatosis with polyangiitis is a rare and potentially fatal disease if not readily diagnosed. Cerebral involvement is extremely rare and clinical presentation as hemorrhagic stroke is even rarer. Case presentation A 58-year-old Caucasian man was admitted to our medical unit because of a computed tomography-diagnosed hemorrhagic stroke with right-sided hemiparesis and fever. A chest computed tomography scan also revealed multiple bilateral pulmonary infiltrates; coronary artery, and carotid and left vertebral artery calcifications were also observed. Empiric antimicrobial therapy with cephalosporins was promptly undertaken; low-molecular-weight heparin was intr…

MalePathologymedicine.medical_specialtyChurg-Strauss polyangiitisSettore MED/09 - Medicina Internaeosinophilic granulomatosiCase ReportSelf MedicationChurg-Strauss SyndromeCoronary AngiographyAdrenal Cortex HormonesEosinophilicMedicineHumansChurg–Strauss syndromeCorticosteroidsLeukocytosisSelf-medicationStrokeLungAnti-neutrophil cytoplasmic antibodyMedicine(all)medicine.diagnostic_testbusiness.industryEosinophilic granulomatosis with polyangiitisGeneral MedicineCerebral InfarctionMiddle AgedSubarachnoid Hemorrhagemedicine.diseaseCoronary arteriesStrokemedicine.anatomical_structureAngiographymedicine.symptombusinessGranulomatosis with polyangiitisImmunosuppressive AgentsSystemic vasculitis
researchProduct

Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study

2017

The natural history and its modulation by treatments administered for immune thrombocytopenia (ITP) in the clinical practice remains unknown. In addition, little information is available on the characteristics and management of ITP in Spain. We conducted an observational, multicenter, registry in 70 Hematology Services from Spain between 2009 and 2011, which included children from 2 months of age and adults with primary ITP or another ITP diagnosed within the last 6 months (platelet count [PC]  484 patients were included (median [Q1, Q3] age 52 [29,74] years, 87.6% adults), 56% women, 10.5% with secondary ITP. Median (Q1, Q3) PC at diagnosis was 12 × 109/l (4, 32); 72% of patients had bleed…

MalePediatricsRegistry studyComorbidity030204 cardiovascular system & hematologycorticosteroids0302 clinical medicineAdrenal Cortex Hormonesimmune system diseaseshemic and lymphatic diseasesRegistriesChildresponseHematologyDisease ManagementImmunoglobulins IntravenousHematologyMiddle AgedClinical PracticeNatural historyPhenotypeTreatment OutcomeIntravenous ImmunoglobulinsChild PreschoolFemaleAlgorithmsAdultmedicine.medical_specialtyAdolescentHemorrhageintravenous immunoglobulinsYoung Adult03 medical and health sciencesImmune systemInternal medicinemedicineHumansAgedPurpura Thrombocytopenic IdiopathicPlatelet Countbusiness.industryInfantImmune thrombocytopeniaImmune thrombocytopeniaSpainObservational studybusinessBiomarkers030215 immunologyHematology
researchProduct

Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency

2012

Background Vitamin D has effects on the innate and adaptive immune system. In asthmatic children low vitamin D levels are associated with poor asthma control, reduced lung function, increased medication intake, and exacerbations. Little is known about vitamin D in adult asthma patients or its association with asthma severity and control. Methods Clinical parameters of asthma control and 25-hydroxyvitamin D (25(OH)D) serum concentrations were evaluated in 280 adult asthma patients (mean ± SD: 45.0 ± 13.8 yrs., 40% male, FEV1 74.9 ± 23.4%, 55% severe, 51% uncontrolled). Results 25(OH)D concentrations in adult asthmatics were low (25.6 ±11.8 ng/ml) and vitamin D insufficiency or deficiency (vi…

MalePulmonary and Respiratory MedicineCross-sectional studyAsthma severityBMIimmune system diseasesForced Expiratory VolumeAsthma controlPrevalenceVitamin D and neurologyHumansCorticosteroidsMedicineProspective StudiesVitamin DProspective cohort studyLung functionAgedCalcifediolAsthmabusiness.industryResearchBody WeightSputumMiddle AgedVitamin D DeficiencyAcquired immune systemmedicine.diseaseAsthmaInterleukin-10respiratory tract diseasesEosinophilsCross-Sectional StudiesImmunologyFemalebusinessRespiratory Research
researchProduct

Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: Real-life data

2010

SummaryBackgroundLong-term oral corticosteroid (OCS) therapy is associated with significant burden on patients and healthcare resources; treatments that may help reduce their use are important to improve asthma management.MethodsFrench and German clinicians prescribing omalizumab for >16 weeks to patients with severe persistent allergic asthma collected OCS use data. OCS use was recorded at baseline and at a non-specific time point beyond 16 weeks from initiation of omalizumab. The number of asthma exacerbations (FEV1 16 weeks. Of these, 166 (48.0%) were receiving maintenance OCS (France, n = 64; Germany, n = 102). Following omalizumab therapy, 84 (50.6%) patients on OCS at baseline reduced…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyAllergyDatabases Factualmedicine.drug_classAllergic asthmaOmalizumabOmalizumabAntibodies Monoclonal HumanizedImmunoglobulin EAdrenal Cortex HormonesOral administrationGermanyInternal medicineOral corticosteroidsRespiratory HypersensitivityHumansMedicineAnti-Asthmatic AgentsAnti-IgEAsthmabiologybusiness.industryRespiratory diseaseAntibodies MonoclonalMiddle Agedmedicine.diseaseAsthmaAntibodies Anti-IdiotypicSurgeryHospitalizationbiology.proteinPrednisoloneCorticosteroidFemaleFrancebusinessmedicine.drugRespiratory Medicine
researchProduct

D-dimer concentrations in acute urticaria in children

2021

Introduction: Urticaria is a clinical entity presenting as wheals, angioedema, or both simul-taneously. Elevated D-dimer levels were reported in the course of chronic spontaneous urticaria. Data regarding D-dimer levels in acute urticaria in children are limited. Objectives: To assess potential associations between duration of glucocorticosteroid (GCS) therapy and D-dimer concentrations in children with acute urticaria. Patients, materials, and methods: Hospital records of 106 children (59 females), aged 5.57 ± 4.91 years, hospitalized in 2014–2018 were analyzed retrospectively. The study group consisted of pediatric patients admitted to the hospital due to severe acute urticaria resistant …

MalePulmonary and Respiratory Medicinemedicine.medical_specialtypediatricsAdolescentUrticariaImmunologyD-dimersglucocorticosteroidsFibrin Fibrinogen Degradation Products03 medical and health sciences0302 clinical medicinechildrenAmbulatory careInternal medicineWhite blood cellD-dimerHumansImmunology and AllergyMedicinePlateletIn patientacute urticariaChildGlucocorticoidsRetrospective StudiesAcute urticariaAngioedemabusiness.industryDisease ManagementInfantGeneral Medicinemedicine.anatomical_structure030228 respiratory systemChild PreschoolAcute DiseaseAntihistaminic drugsFemalemedicine.symptombusinessBiomarkers030215 immunologyAllergologia et Immunopathologia
researchProduct

Physical and cognitive doping in university students using the unrelated question model (UQM): Assessing the influence of the probability of receivin…

2018

Study objectives: In order to increase the value of randomized response techniques (RRTs) as tools for studying sensitive issues, the present study investigated whether the prevalence estimate for a sensitive item π̂$_{s}$ assessed with the unrelated questionnaire method (UQM) is influenced by changing the probability of receiving the sensitive question p. Material and methods: A short paper-and-pencil questionnaire was distributed to 1.243 university students assessing the 12-month prevalence of physical and cognitive doping using two versions of the UQM with different probabilities for receiving the sensitive question (p ≈ 1/3 and p ≈ 2/3). Likelihood ratio tests were used to assess wheth…

MaleQuestionnairesPeptide Hormoneslcsh:MedicineSocial SciencesBiochemistryMathematical and Statistical Techniques0504 sociologySociologySurveys and QuestionnairesStatisticsPrevalenceMedicine and Health SciencesHuman Performanceddc:796lcsh:ScienceMathematicsDoping in SportsMultidisciplinarySocial ResearchOrganic Compounds05 social sciencesDrugsCognitionMiddle AgedChemistryAthletic & outdoor sports & gamesNeurologyResearch DesignBehavioral PharmacologyPhysical SciencesFemaleSteroidsResearch ArticleAdultAdolescentUniversitiesSubstance-Related DisordersStreet drugsBayesian MethodResearch and Analysis Methods050105 experimental psychologyYoung AdultNeuropharmacologySensitive questionRecreational Drug UseHumans0501 psychology and cognitive sciencesStudentsErythropoietinPharmacologyPsychotropic DrugsBehaviorModels StatisticalSurvey ResearchIllicit Drugslcsh:RAmphetaminesOrganic ChemistryChemical CompoundsCorrection050401 social sciences methodsBiology and Life SciencesHormonesSample size determinationlcsh:QPLoS ONE
researchProduct

Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus

2005

Rhinoviruses are the major trigger of acute asthma exacerbations and asthmatic subjects are more susceptible to these infections. To investigate the underlying mechanisms of this increased susceptibility, we examined virus replication and innate responses to rhinovirus (RV)-16 infection of primary bronchial epithelial cells from asthmatic and healthy control subjects.Viral RNA expression and late virus release into supernatant was increased 50- and 7-fold, respectively in asthmatic cells compared with healthy controls. Virus infection induced late cell lysis in asthmatic cells but not in normal cells. Examination of the early cellular response to infection revealed impairment of virus induc…

MaleRhinovirusvirusesCHILDRENApoptosisResearch & Experimental MedicineINHALED CORTICOSTEROIDSmedicine.disease_causeVirus ReplicationImmunology and AllergyTRANSCRIPTIONCells CulturedCaspase 7Caspase 311 Medical And Health SciencesMiddle AgedMedicine Research & ExperimentalCaspasesRNA ViralFemalemedicine.symptomRhinovirusLife Sciences & BiomedicineEXPRESSIONAdultVIRUSESImmunologyInflammationBronchiBiologyAntiviral AgentsVirusArticleImmune systemINFLAMMATIONImmunitymedicineKINASELOWER AIRWAYSHumansInnate immune systemScience & TechnologyPicornaviridae InfectionsRECEPTOREpithelial CellsInterferon-betaAsthmaImmunity InnateEXACERBATIONSViral replicationGene Expression RegulationApoptosisImmunology
researchProduct